Inventage Lab, Inc.

A389470

KR7389470006

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
11,830 ^KRW	-4.83%		+13.53%	-32.01%

2023	Inventage Lab, Inc. announced that it has received KRW 18.49998452 billion in funding from The Korea Securities Finance Corporation, Shinhan Bank	CI
2023	Inventage Lab to Raise 3 Billion Won via Stock Sale	MT

Inventage Lab, Inc. has filed an IPO.

May 10, 2022 at 12:00 am EDT

Inventage Lab, Inc. has filed an IPO.

Security Name: Common Stock
Security Type: Common Stock
PriceRange: KRW 25000 to KRW 32000

Transaction Features: ESOP Related Offering; Sponsor Backed Offering

Latest news about Inventage Lab, Inc.

Inventage Lab, Inc. announced that it has received KRW 18.49998452 billion in funding from The Korea Securities Finance Corporation, Shinhan Bank	23-06-18	CI
Inventage Lab to Raise 3 Billion Won via Stock Sale	23-06-11	MT
Inventage Lab, Inc. announced that it expects to receive KRW 18.499980645 billion in funding from The Korea Securities Finance Corporation, Shinhan Bank	23-06-08	CI
Inventage Lab, Inc. has completed an IPO in the amount of KRW 12.48 billion.	22-11-16	CI
Inventage Lab, Inc. has filed an IPO.	22-05-10	CI

Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
INVENTAGE LAB, INC.	-32.01%	72.92M
ELI LILLY AND COMPANY	+43.61%	749B
NOVO NORDISK A/S	+39.42%	605B
JOHNSON & JOHNSON	-6.37%	351B
MERCK & CO., INC.	+19.66%	328B
ABBVIE INC.	+8.15%	292B
NOVARTIS AG	+11.92%	216B
ROCHE HOLDING AG	-2.62%	214B
PFIZER, INC.	+1.75%	167B
AMGEN INC.	+7.23%	165B

Other Pharmaceuticals